Chlorthalidone Recall: Patients Urged to Check Their Blood Pressure Tablets
A recall affecting more than 25,000 bottles of chlorthalidone tablets has prompted patients to check their medication and speak with a pharmacist if they believe they may have an affected batch.
Chlorthalidone is a prescription diuretic commonly used to help manage high blood pressure and fluid retention. Because medicines used to control blood pressure are generally taken regularly, any quality issue can understandably cause concern for patients who rely on them as part of their treatment.
The recall involves specific batches of 25mg chlorthalidone tablets distributed in the United States. The action was initiated voluntarily by the manufacturer and concerns a manufacturing quality issue involving how the tablets dissolve.
Why has chlorthalidone been recalled?
According to the recall information described in the supplied report, Inventia Healthcare Limited initiated a voluntary recall in September 2026 involving 13,567 bottles of 25mg chlorthalidone tablets.
The reason given was that the affected tablets did not meet their required dissolution specification.
Dissolution testing is an important part of pharmaceutical quality control. It examines how a tablet releases its active ingredient under controlled laboratory conditions. If a medicine does not dissolve as expected, there can be uncertainty about whether the intended amount of active ingredient is released appropriately.
The FDA maintains information about drug recalls and explains that recalls can be initiated voluntarily by manufacturers, with the agency overseeing the recall process and assessing the effectiveness of measures taken to remove affected products from the market.
The issue does not mean that every chlorthalidone tablet has been recalled. Patients should therefore check the specific product and batch information rather than assuming that all medicines containing chlorthalidone are affected.
More than 25,000 bottles affected
The latest recall is not the only action involving the product.
A previous recall was initiated in June 2026 and involved another 11,460 bottles. When the two reported recalls are combined, the total number of affected bottles is 25,027.
The affected products include specific batches of chlorthalidone tablets supplied in bottles containing 100 tablets.
The information provided in the original report identifies the following batches:
September 2026 recall
Batch: RISA24002
Strength: 25mg
Bottle size: 100 tablets
NDC: 64980-599-01
Number of bottles: 13,567
Expiry: April 2027
June 2026 recall
Batch: RISA24001
Strength: 25mg
Bottle size: 100 tablets
NDC: 64980-599-01
Number of bottles: 11,460
The supplied material also identifies another batch reference, RISB24002, associated with 1,000-tablet bottles. Patients should rely on the official recall notice and their pharmacist when determining whether their particular medicine is affected.
What is chlorthalidone used for?
Chlorthalidone belongs to a group of medicines known as diuretics. These medicines are sometimes called "water tablets" because they encourage the kidneys to remove excess salt and water from the body.
It is commonly prescribed for high blood pressure. It may also be used to help manage fluid retention associated with certain medical conditions.
The FDA describes chlorthalidone as a medicine used for the treatment of hypertension and edema.
For many people, controlling high blood pressure requires taking medication consistently alongside other measures such as maintaining a balanced diet, being physically active where appropriate, limiting excess salt and attending regular medical appointments.
Because chlorthalidone can increase urination, some patients may be instructed to take it earlier in the day. However, patients should follow the specific instructions given by their doctor or pharmacist rather than changing the timing themselves.
What should patients do if they have chlorthalidone?
Patients who take chlorthalidone should not stop their medication simply because they have seen a recall report.
Stopping blood pressure medication without medical advice can allow blood pressure to rise and may increase health risks.
Instead, check the label on the medicine bottle and compare the batch or lot information with the details contained in the official recall notice.
The FDA advises consumers who are concerned about a recalled medicine to check the lot number on the product against the information provided in the recall announcement. Patients can also contact the pharmacy that dispensed the medication.
If the batch is affected, the pharmacist can explain what should happen next and whether another supply should be provided.
Patients who cannot determine whether their medicine is affected should also seek advice from a pharmacist rather than guessing.
Why does the dissolution issue matter?
A tablet needs to release its active ingredient appropriately after it is taken. Dissolution testing is therefore an important part of ensuring that a medicine performs as expected.
The FDA has specific dissolution requirements and testing guidance for oral medicines, including chlorthalidone tablets.
A failure to meet a dissolution specification is a product quality concern. It does not automatically mean that every tablet will cause harm, but it means the affected product does not meet the required quality standard.
This is why recalls are used as a precautionary measure. Removing affected batches from distribution can reduce the possibility that patients receive medicine that does not meet the required specifications.
How can patients check their medicine?
The simplest first step is to locate the pharmacy label and the manufacturer's information on the bottle.
Patients should look for the product name, strength, National Drug Code where applicable, and batch or lot number.
They should then contact the pharmacy that supplied the medicine and ask whether their particular batch is included in the recall.
If the medication is confirmed as part of the recall, patients should ask the pharmacist what alternative supply is appropriate.
People who have questions about their treatment should not rely solely on information circulating online or on social media. Prescription medicines are individual treatments, and the safest course is to obtain advice from a qualified healthcare professional.
The wider importance of medication recalls
Drug recalls are an established part of pharmaceutical safety monitoring.
Not every recall indicates a serious immediate danger to patients. Some are issued because a product does not meet a manufacturing or quality specification, while others can involve issues such as contamination, incorrect labelling or packaging problems.
The FDA explains that a recall is one of the mechanisms used to remove defective or potentially harmful medicines from the market. The agency also monitors the steps taken by manufacturers during the recall process.
For consumers, the important point is to respond calmly and obtain accurate information.
Patients should check whether their specific medicine is affected, contact their pharmacist if necessary, and avoid making sudden changes to prescribed treatment without professional advice.
What happens next?
The affected batches are expected to be removed from distribution as part of the recall process.
Patients who have the recalled product should follow instructions from their pharmacist or healthcare provider regarding replacement medication and disposal or return of the affected tablets.
Official recall information can change as regulators and manufacturers provide further updates. The FDA maintains a dedicated database of drug recalls and other safety information for consumers and healthcare professionals.
Anyone who experiences a concerning symptom or believes they have been affected by a medication problem should seek appropriate medical advice promptly.
Sources
- U.S. Food and Drug Administration, Drug Recalls.
- U.S. Food and Drug Administration, Chlorthalidone Oral Tablet guidance.
Disclaimer
This article is for general information only and is not medical advice. It should not be used to diagnose, treat or prevent a medical condition or to replace advice from a doctor, pharmacist or other qualified healthcare professional. Patients taking chlorthalidone should not stop or change their prescribed medication without speaking to an appropriate healthcare professional. Recall information can change, so readers should check the latest official FDA or manufacturer notice and confirm the batch details with their pharmacist.